Monte Rosa Therapeutics, Inc. (GLUE)
NASDAQ·Healthcare·Biotechnology
$19.05
-1.24%
Mkt Cap $1.31B
Analyst Ratings
Buy
6
Hold
1
Sell
0
Price Target (5 analysts)
$31.75
Range $22.00 – $37.00
Implied Upside
+66.7%
Consensus $31.75 vs current $19.05
NASDAQ·Healthcare·Biotechnology
$19.05
-1.24%
Mkt Cap $1.31B
Buy
6
Hold
1
Sell
0
Price Target (5 analysts)
$31.75
Range $22.00 – $37.00
+66.7%
Consensus $31.75 vs current $19.05